TD Waterhouse Canada’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.2K Sell
301
-300
-50% -$39.1K ﹤0.01% 1491
2025
Q4
$73.1K Hold
601
﹤0.01% 1113
2025
Q3
$69K Buy
601
+126
+27% +$14.7K ﹤0.01% 1118
2025
Q2
$61.7K Sell
475
-125
-21% -$13.7K ﹤0.01% 1082
2025
Q1
$41K Buy
600
+175
+41% +$12K ﹤0.01% 1126
2024
Q4
$26.5K Sell
425
-4,173
-91% -$388K ﹤0.01% 1218
2024
Q3
$669K Buy
4,598
+4,548
+9,096% +$701K 0.01% 565
2024
Q2
$7.5K Buy
+50
New +$6K ﹤0.01% 1417

Other funds holding TMDX

TD Waterhouse Canada's TMDX Position: Q1 2026 in Review

TD Waterhouse Canada reduced its Transmedics (TMDX) stake by 50% in Q1 2026, selling an estimated $39.1K and leaving 301 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

TD Waterhouse Canada first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $669K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • TD Waterhouse Canada held 301 shares of Transmedics worth $30.2K as of Q1 2026.
  • TD Waterhouse Canada sold 300 Transmedics shares in Q1 2026, an estimated $39.1K.
  • Transmedics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1491 holding.
  • TD Waterhouse Canada first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • TD Waterhouse Canada's Transmedics position peaked at $669K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.